FDA opens dialogue on nanotechnology regulation
According to FDA Commissioner Margaret A. Hamburg: Our goal is to regulate these products using the best possible science. Understanding nanotechnology remains a top priority within the agency’s regulatory science initiative and, in doing so, we will be prepared to